0001104659-22-040613 | 20-F | XBRL Viewer

Local exemption rules applied by subsidiaries of the Group	12 Months Ended
Dec. 31, 2021
Local exemption rules applied by subsidiaries of the Group
Local exemption rules applied by subsidiaries of the Group	2. Local exemption rules applied by subsidiaries of the Group Affimed GmbH, Heidelberg, Germany, makes use of the exemption clause, available under § 264 (3) HGB in 2021. The consolidated financial statements of Affimed N.V. as of and for the year ended 31 December 2021 will be filed in Germany as a supplement to the financial statements of Affimed GmbH, in order to meet the requirements of the exemption clause available under § 264 (3) HGB in 2021.

Other income and expenses - net (Details) - EUR (€) € in Thousands	12 Months Ended
Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Other income and expenses - net.
Research collaborations	€ 1,072	€ 0	€ 0

Label

Element

Value

Borrowings Outstanding

afmd_BorrowingsOutstanding

€ 231,000

Borrowings Outstanding

afmd_BorrowingsOutstanding

323,000

Borrowing Cost Capitalised

afmd_BorrowingCostCapitalised

(91,000)

Borrowing Cost Capitalised

afmd_BorrowingCostCapitalised

68,000

Debt Instrument, Monthly Repayment Installment Amount

afmd_DebtInstrumentMonthlyRepaymentInstallmentAmount

8,000

Debt Instrument, Monthly Repayment Installment Amount

afmd_DebtInstrumentMonthlyRepaymentInstallmentAmount

8,000

Lease Contract, Monthly Rent

afmd_LeaseContractMonthlyRent

116,000

Tax loss carryforward for corporate income tax purposes

afmd_OperatingLossCarryforwardsForCorporateIncomeTaxPurposes

288,600,000

Tax loss carryforward for corporate income tax purposes

afmd_OperatingLossCarryforwardsForCorporateIncomeTaxPurposes

233,700,000

Tax loss carryforward for corporate income tax purposes

afmd_OperatingLossCarryforwardsForCorporateIncomeTaxPurposes

20,000

Tax loss carryforward for corporate income tax purposes

afmd_OperatingLossCarryforwardsForCorporateIncomeTaxPurposes

€ 803,000

Disclosure Of Long Term Financial Assets [Text Block]

afmd_DisclosureOfLongTermFinancialAssetsTextBlock

15. Long-term financial assets

The Group holds preferred shares in Amphivena previously recognized at their fair value of €2.9 million . In early October 2021, the Board of Amphivena made the decision to wind down the company, and we believe the decision indicates that the investment is fully impaired. Based on current information, we estimate that the investment has a fair value of nil. This fair value change has resulted in an impairment of €2.9 million and has been recognized in other comprehensive income.

The Group also holds common shares in Roivant at their fair value of €12.3 million as of December 31, 2021 (2020: €17.1 million). The overall decrease in the fair value of €4.8 million has been recognized in other comprehensive income. As of December 31, 2020, the fair value of this investment was categorised as Level 3 and was based on observable financing round valuations which was adjusted considering certain assumptions such as the development of quoted market prices of peer companies and other publicly available information as well as quantitative and qualitative information provided by Roivant. During 2021, Roivant listed its common shares on a stock exchange (Nasdaq, US) and they are currently actively traded in that market. Therefore, fair value measurement was transferred from Level 3 to Level 1 of the fair value hierarchy at October 1, 2021, at which time the fair value of the shares was recorded at €11.2 million. As at December 31, 2021 the fair value of the shares in Roivant was based on its quoted market price. Refer to note 27 regarding events that took place subsequent to December 31, 2021.

Lease Contract, One time payment for Laboratory Construction

afmd_LeaseContractOneTimePaymentForLaboratoryConstruction

€ 696,000

Collaboration Agreement Cash Consideration

afmd_CollaborationAgreementCashConsideration

€ 40,000,000

I F R S Line of Credit Facility, Maximum Borrowing Capacity"

afmd_IFRSLineOfCreditFacilityMaximumBorrowingCapacity

€ 5,000,000.0

I F R S Line of Credit Facility, Maximum Borrowing Capacity"

afmd_IFRSLineOfCreditFacilityMaximumBorrowingCapacity

25,000,000

Tax loss carryforward for trade tax purposes

afmd_OperatingLossCarryforwardsForTradeTaxPurposes

287,700,000

Tax loss carryforward for trade tax purposes

afmd_OperatingLossCarryforwardsForTradeTaxPurposes

234,600,000

Lease Contract, Security Deposit

afmd_LeaseContractSecurityDeposit

€ 413,000

Number Of Shareholders Holding More Than Twenty Percent Voting Rights

afmd_NumberOfShareholdersHoldingMoreThanTwentyPercentVotingRights

Number Of Shareholders Holding More Than Twenty Percent Voting Rights

afmd_NumberOfShareholdersHoldingMoreThanTwentyPercentVotingRights

Remuneration payable to key management personnel and supervisory directors